e-learning
resources
Virtual 2020
Pre-Congress Content
Pulmonary embolism and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endothelin-1 gen (EDN1) regulating miRNAs are downregulated in Idiopathic Pulmonary Arterial Hypertension
A. Baloira Villar (Pontevedra, Spain), M. Lago Docampo (Pontevedra, Spain), C. López (Pontevedra, Spain), C. Vilariño (Pontevedra, Spain), J. Barberá (Barcelona, Spain), I. Blanco (Barcelona, Spain), D. Valverde (Pontevedra, Spain)
Source:
Virtual Congress 2020 – Pulmonary embolism and beyond
Session:
Pulmonary embolism and beyond
Session type:
E-poster session
Number:
3461
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Baloira Villar (Pontevedra, Spain), M. Lago Docampo (Pontevedra, Spain), C. López (Pontevedra, Spain), C. Vilariño (Pontevedra, Spain), J. Barberá (Barcelona, Spain), I. Blanco (Barcelona, Spain), D. Valverde (Pontevedra, Spain). Endothelin-1 gen (EDN1) regulating miRNAs are downregulated in Idiopathic Pulmonary Arterial Hypertension. 3461
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Inhibition of the miRNA familiy miR-130 restores the expression of CDKN1A (p21) and ameliorates hypoxia-induced pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Functional study of polymorphisms in the promoter region of the endothelin-1 gene in Pulmonary Arterial Hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Mutational and epigenetic analysis of the promoter region of
BMPR2
gene in patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014
Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Neuron-derived orphan receptor 1 mediated human pulmonary arterial smooth muscle cells proliferation via cyclin D1
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
LATE-BREAKING ABSTRACT: The bromodomain-containing protein 4: the epigenetic origin of the oncogenic signature in pulmonary hypertension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Right heart hypertrophy in mice deficient of the mitochondrial regulator protein p66shc is decreased after chronic hypoxic exposure by a cyclophilin D dependent mechanism
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
PKCalpha deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A
2
via increased TXA
2
receptor expression
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Identification of profibrotic cells in the Idiopathic Pulmonary Fibrosis (IPF) lung
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Contribution of BMP9 to Pulmonary Arterial Hypertension
Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension
Year: 2017
M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
miR-126; link between angiogenesis and exercise intolerance in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Immunity in idiopathic pulmonary arterial hypertension (IPAH), a role for activated DCs?
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
LSC 2014 abstract - Combined effects of inflammatory mediators and BMPR2 mutation on pulmonary arterial cell function in a pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept